Persistent Asset Partners’s Yarrow Bioscience YARW Stock Holding History

Persistent Asset Partners’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$69.6K	Buy	+3,092	New	+$105K	0.02%	369

Other funds holding YARW

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $854M AUM 179.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Monashee Investment Management Boston, Massachusetts $33.4M AUM 92.4% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return

Aster Capital Management Dubai, United Arab Emirates $275M AUM 18.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

MB, Levis & Associates Center Valley, Pennsylvania $273M AUM 8.08% 1-Year Est. Return

Persistent Asset Partners's YARW Position: Q3 2026 in Review

Persistent Asset Partners opened a new position in Yarrow Bioscience (YARW) in Q3 2026: 3,092 shares worth $69.6K. The stake represents 0.02% of the portfolio and ranks #369 among its holdings.

13 funds tracked by Wall St. Rank hold YARW as of Q3 2026.

Persistent Asset Partners held 3,092 shares of Yarrow Bioscience worth $69.6K as of Q3 2026.
Yarrow Bioscience was a new Persistent Asset Partners position in Q3 2026.
Yarrow Bioscience made up 0.02% of Persistent Asset Partners's portfolio in Q3 2026, its #369 holding.
13 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2026.

Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.